×
About 3,258 results

ALLMedicine™ Salpingo-oophorectomy Center

Research & Reviews  1,121 results

Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma...
https://doi.org/10.1097/PAS.0000000000001915
The American Journal of Surgical Pathology; Agaimy A, Clarke BA et. al.

May 17th, 2022 - With the widespread application of next-generation sequencing, the genetic landscape of uterine mesenchymal neoplasms has been evolving rapidly to include several recently identified fusion genes. Although chromosomal rearrangements involving the ...

The surgical menopause.
https://doi.org/10.1016/j.bpobgyn.2022.03.001
Best Practice & Research. Clinical Obstetrics & Gynaecology; C Pillay O, Manyonda I

May 15th, 2022 - Surgical menopause (iatrogenic menopause) happens when both ovaries are removed before the natural "switching off" of ovarian function; it can cause premature ovarian insufficiency where the menopause occurs in women before the age of 40. Surgical...

Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan:...
https://doi.org/10.3802/jgo.2022.33.e46
Journal of Gynecologic Oncology; Sekine M, Enomoto T et. al.

May 14th, 2022 - BRCA1 and BRCA2 mutation carriers are recommended to undergo risk-reducing salpingo-oophorectomy (RRSO) by age 40 and 45, respectively. However, the carriers have a different way of thinking about their life plan. We aimed to investigate the distr...

TP53 variants in p53 signatures and the clonality of STICs in RRSO samples.
https://doi.org/10.3802/jgo.2022.33.e50
Journal of Gynecologic Oncology; Akahane T, Masuda K et. al.

May 14th, 2022 - Precursor lesions may be identified in fallopian tube tissue after risk-reducing salpingo-oophorectomy (RRSO) in patients with pathogenic variants of BRCA1/2. Serous tubal intraepithelial carcinoma (STIC) is considered a precursor of high-grade se...

Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study.
https://doi.org/10.3802/jgo.2022.33.e51
Journal of Gynecologic Oncology; do Valle HA, Kaur P et. al.

May 14th, 2022 - Examine the risks of fractures and osteoporosis after risk-reducing bilateral salpingo-oophorectomy (RRBSO) among women with BRCA1/2 mutations. In this retrospective population-based study in British Columbia, Canada, between 1996 to 2017, we comp...

see more →

Guidelines  4 results

Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below th...
https://doi.org/10.1111/1471-0528.16896
BJOG : an International Journal of Obstetrics and Gynaeco... Manchanda R, Gaba F et. al.

Oct 22nd, 2021 - This paper deals with the use of hormone replacement therapy (HRT) after the removal of fallopian tubes and ovaries to prevent ovarian cancer in premenopausal high risk women. Some women have an alteration in their genetic code, which makes them m...

No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
https://doi.org/10.1016/j.jogc.2018.05.046
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Jacobson M, Bernardini M et. al.

Nov 27th, 2018 - This Committee Opinion outlines the gynaecologic management recommendations for women diagnosed with hereditary breast and ovarian cancer syndrome (HBOC) with respect to screening, contraception, chemoprophylaxis, fertility considerations, risk-re...

Committee Opinion No. 685: Care for Transgender Adolescents.
https://doi.org/10.1097/AOG.0000000000001861
Obstetrics and Gynecology;

Dec 22nd, 2016 - Gender nonconforming youth are an underserved population who obstetrician-gynecologists are seeing increasingly in their practices. Currently, there are large gaps in training, knowledge, and comfort with transgender patients among obstetrician-gy...

ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy.
https://doi.org/10.1097/01.AOG.0000291580.39618.cb
Obstetrics and Gynecology;

Jan 1st, 2008 - ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy.|2008| ,|standards,surgery,methods,genetics,prevention & control,standards,

see more →

Clinicaltrials.gov  36 results

Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
https://clinicaltrials.gov/ct2/show/NCT01048853

May 2nd, 2022 - PRIMARY OBJECTIVE: I. To evaluate the safety and feasibility of performing conservative surgery in women with stage IA2 or IB1 carcinoma of the cervix with favorable pathologic features. SECONDARY OBJECTIVES: I. To estimate the cervix cancer recur...

OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk
https://clinicaltrials.gov/ct2/show/NCT05333328

Apr 25th, 2022 - Among ER+HER2- premenopausal patients with N1 who undergoes primary breast surgery, we will identify the patients with a genomic low risk using the multigene-assay (OncoFREE®). In these, ovarian function suppression (OFS) with endocrine therapies ...

Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy
https://clinicaltrials.gov/ct2/show/NCT04429022

Apr 18th, 2022 - Material and Methods: This is a prospective cohort study with historical controls. Cases of those receiving a non-opioid multimodal pain regimen will be compared to historical controls of those receiving a traditional opioid pain regimen. All pati...

A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
https://clinicaltrials.gov/ct2/show/NCT04251052

Apr 15th, 2022 - PRIMARY OBJECTIVE: I. To compare the non-inferiority of bilateral salpingectomy (BLS) with delayed oophorectomy to bilateral salpingo-oophorectomy (BSO) to reduce the risk of ovarian cancer among women with deleterious BRCA1 germline mutations. SE...

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations
https://clinicaltrials.gov/ct2/show/NCT02760849

Feb 28th, 2022 - PRIMARY OBJECTIVES: I. To examine changes in female sexual function with the strategy of interval salpingectomy and delayed oophorectomy (ISDO) compared to the strategy of risk-reducing salpingo-oophorectomy (RRSO) for patients who carry genetic m...

see more →

News  142 results

HT for women who have had BSO before the age of natural menopause: Discerning the nuances
https://www.mdedge.com/obgyn/article/251559/menopause/ht-women-who-have-had-bso-age-natural-menopause-discerning-nuances
Stephanie Faubion, MD, MBA, NCMP, Andrew M. Kaunitz, MD, NCMP et. al.

Feb 8th, 2022 - Women who undergo bilateral salpingo-oophorectomy (BSO) for various indications prior to menopause experience a rapid decline in ovarian hormone levels and consequent vasomotor and other menopausal symptoms. In addition, the resulting estrogen dep.

Breast Cancer Survivors Have Specific Gynecological Needs
https://www.medscape.com/viewarticle/950630

May 6th, 2021 - Sexual dysfunction is a common problem among breast cancer survivors, but it's also an issue inadequately addressed by either ob/gyns. or hematologists and oncologists, according to Erin Keyser, MD, the program director of the San Antonio Uniforme...

Prophylactic Oophorectomy for Reducing Ovarian Cancer Risk
https://www.onclive.com/view/prophylactic-oophorectomy-for-reducing-ovarian-cancer-risk

Apr 2nd, 2021 - For High-Definition, Click Prophylactic bilateral salpingo-oophorectomy is the best strategy for reducing the risk of ovarian cancer in BRCA-positive women, notes Warner K. Huh, MD. Risk is reduced by over 90% in high-risk individuals, adds Robe...

Germline Genetic Testing Raises Thorny Ethical Questions
https://www.onclive.com/view/germline-genetic-testing-raises-thorny-ethical-questions

Mar 29th, 2021 - Maurie Markman, MD The simply stunning advances in our understanding of the molecular basis of human disease are providing revolutionary changes in the management of multiple illnesses. It is well recognized that cancer has been at the leading ed...

Risk-Reducing Salpingo-Oophorectomy Could Curb Breast Cancer
https://www.medscape.com/viewarticle/947109

Mar 11th, 2021 - NEW YORK (Reuters Health) - In women with pathogenic variants in BRCA1 and BRCA2, risk-reducing salpingo-oophorectomy (RRSO) to help avoid ovarian cancer also appears to reduce breast-cancer risk, particularly within five years of surgery, accordi...

see more →